Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy
Top Cited Papers
- 24 July 2015
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 349 (6246), 436-440
- https://doi.org/10.1126/science.aaa1663
Abstract
Mutations in the LRBA gene (encoding the lipopolysaccharide-responsive and beige-like anchor protein) cause a syndrome of autoimmunity, lymphoproliferation, and humoral immune deficiency. The biological role of LRBA in immunologic disease is unknown. We found that patients with LRBA deficiency manifested a dramatic and sustained improvement in response to abatacept, a CTLA4 (cytotoxic T lymphocyte antigen-4)–immunoglobulin fusion drug. Clinical responses and homology of LRBA to proteins controlling intracellular trafficking led us to hypothesize that it regulates CTLA4, a potent inhibitory immune receptor. We found that LRBA colocalized with CTLA4 in endosomal vesicles and that LRBA deficiency or knockdown increased CTLA4 turnover, which resulted in reduced levels of CTLA4 protein in FoxP3+ regulatory and activated conventional T cells. In LRBA-deficient cells, inhibition of lysosome degradation with chloroquine prevented CTLA4 loss. These findings elucidate a mechanism for CTLA4 trafficking and control of immune responses and suggest therapies for diseases involving the CTLA4 pathway.Keywords
Funding Information
- NIH (1RC2 HG005608)
- National Institute of Allergy and Infectious Diseases
- American Society of Hematology
- Merck, Inc.
- Cincinnati Children’s Hospital Medical Center
This publication has 35 references indexed in Scilit:
- LRBA gene deletion in a patient presenting with autoimmunity without hypogammaglobulinemiaJournal of Allergy and Clinical Immunology, 2012
- Deleterious Mutations in LRBA Are Associated with a Syndrome of Immune Deficiency and AutoimmunityAmerican Journal of Human Genetics, 2012
- Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell ActivationJournal of Biological Chemistry, 2012
- Morbidity and mortality in common variable immune deficiency over 4 decadesBlood, 2012
- The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responsesNature Reviews Immunology, 2011
- Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trialAnnals Of The Rheumatic Diseases, 2011
- Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditionsBritish Journal of Haematology, 2009
- Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific mannerBlood, 2007
- SEL-2, theC. elegansneurobeachin/LRBA homolog, is a negative regulator oflin-12/Notchactivity and affects endosomal traffic in polarized epithelial cellsDevelopment, 2007
- Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4Science, 1995